167 related articles for article (PubMed ID: 15526017)
1. Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma.
Lau LG; Tan LK; Koay ES; Liu TC
Leukemia; 2005 Feb; 19(2):299-301. PubMed ID: 15526017
[No Abstract] [Full Text] [Related]
2. [B-cell acute lymphoblastic leukemia developed 5 years after autologous stem cell transplantation for multiple myeloma].
Tsukada Y; Hattori Y; Nakajima H; Yokoyama K; Murata M; Shimizu N; Kondo N; Okamoto S
Rinsho Ketsueki; 2012 Feb; 53(2):219-23. PubMed ID: 22450582
[TBL] [Abstract][Full Text] [Related]
3. Early onset of acute lymphoblastic leukemia with MLL rearrangement after autologous stem cell transplantation for multiple myeloma.
Ueda K; Yamamoto G; Shinohara A; Hangaishi A; Kurokawa M
Ann Hematol; 2009 Aug; 88(8):813-4. PubMed ID: 19127363
[No Abstract] [Full Text] [Related]
4. Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.
Merlin F; Prochilo T; Kildani B; Tucci A; Ferrari S; Rossi G; D'Adda P; Beretta GD
Acta Oncol; 2008; 47(3):464-6. PubMed ID: 17851873
[No Abstract] [Full Text] [Related]
5. Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma.
Konishi Y; Tada K; Nishi K; Imada K
Ann Hematol; 2016 Oct; 95(10):1739-40. PubMed ID: 27473192
[No Abstract] [Full Text] [Related]
6. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
7. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
Comenzo RL; Hassoun H; Kewalramani T; Klimek V; Dhodapkar M; Reich L; Teruya-Feldstein J; Fleisher M; Filippa D; Nimer SD
Leukemia; 2006 Feb; 20(2):345-9. PubMed ID: 16319952
[TBL] [Abstract][Full Text] [Related]
8. [The probability of the carcinogenic risk of using nitrosomethylurea for treating cancer patients].
Korman DB
Vopr Onkol; 2000; 46(3):274-7. PubMed ID: 10976271
[TBL] [Abstract][Full Text] [Related]
9. [Acute leukemia as secondary neoplasms in children with advanced lymphomas].
Maluf Júnior PT; Cristofani L; Britto JL; Odone Filho V
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):24-6. PubMed ID: 8029611
[TBL] [Abstract][Full Text] [Related]
10. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.
Hequet O; Dumontet C; El Jaafari-Corbin A; Salles G; Espinouse D; Arnaud P; Thieblemont C; Bouafia F; Coiffier B
Bone Marrow Transplant; 2002 Mar; 29(6):544. PubMed ID: 11960281
[No Abstract] [Full Text] [Related]
11. AML transformation after autologous stem cell transplant for multiple myeloma.
Gupta SK; Chandramohan J; Kumar L
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26025976
[TBL] [Abstract][Full Text] [Related]
12. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
13. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
14. [Malignant lymphoma with c-myc gene rearrangement in a patient receiving long-term treatment for multiple myeloma].
Ohnishi H; Kamimura T; Gondo H; Okamura T; Niho Y; Yao T
Rinsho Ketsueki; 1999 Dec; 40(12):1265-70. PubMed ID: 10658480
[TBL] [Abstract][Full Text] [Related]
15. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Gasparetto C; Gockerman JP; Diehl LF; de Castro CM; Moore JO; Long GD; Horwitz ME; Keogh G; Chute JP; Sullivan KM; Neuwirth R; Davis PH; Sutton LM; Anderson RD; Chao NJ; Rizzieri D
Biol Blood Marrow Transplant; 2010 Jan; 16(1):70-7. PubMed ID: 19733251
[TBL] [Abstract][Full Text] [Related]
16. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
17. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
van Imhoff GW; van der Holt B; MacKenzie MA; Ossenkoppele GJ; Wijermans PW; Kramer MH; van 't Veer MB; Schouten HC; van Marwijk Kooy M; van Oers MH; Raemaekers JM; Sonneveld P; Meulendijks LA; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
Leukemia; 2005 Jun; 19(6):945-52. PubMed ID: 15800666
[TBL] [Abstract][Full Text] [Related]
18. Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support.
Iversen PO; Wisløff F; Gulbrandsen N
Clin Nutr; 2010 Aug; 29(4):488-91. PubMed ID: 20044183
[TBL] [Abstract][Full Text] [Related]
19. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
[No Abstract] [Full Text] [Related]
20. Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation.
Fenk R; Neubauer F; Bruns I; Schröder T; Germing U; Haas R; Kobbe G
Br J Haematol; 2012 Mar; 156(5):683-6. PubMed ID: 22050384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
